Jiyi Choi, Moon Gyeong Yoon, Se Ha Jang, Geum Ok Baek, Hyun Sun Jung, Na-Rae Lee, Choong Hwan Lee, Ji Eun Han, Jae Youn Cheong, Jung Woo Eun, Soon Sun Kim
Clin Mol Hepatol 2026;32(1):239-257. Published online October 27, 2025
Background/Aims Gut microbiome plays a pivotal role in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis, yet, associated functional mechanisms and host responses of specific microbial species remain insufficiently characterized. This study investigated the Bacteroides eggerthii therapeutic effects on MASLD by integrating multi-omics analysis and experimental validation in a Western diet (WD)-induced mouse model.
Methods Candidate strains were identified using 16S rRNA gene sequencing of fecal samples from individuals with and without MASLD or obesity. B. eggerthii, a species significantly depleted in both groups, was selected for functional evaluation. Male C57BL/6J mice were fed a WD or WD supplemented with B. eggerthii (WD+B) for 12 weeks. Liver histology, serum biochemistry, fecal microbiome and metabolome profiling, and hepatic and intestinal transcriptomic analyses were performed. Anti-steatotic effects of B. eggerthii–derived metabolites were validated in vitro.
Results Bacteroides eggerthii supplementation significantly improved liver weight, inflammation, fibrosis, and steatosis in WD+B group compared to WD alone. PICRUSt-based LEfSe analysis revealed choloylglycine hydrolase activity enrichment in gut microbiota, and strain-specific qPCR confirmed colonization in mouse colon. Integrated transcriptomic analyses revealed lipid and bile acid signaling pathway restoration, including CD36, FXR, and FGF15. Untargeted metabolomics identified elevated 2-hydroxyisocaproic acid (HICA) as a strain-derived metabolite in feces and B. eggerthii culture supernatants. In vitro, HICA significantly reduced lipid accumulation in free fatty acid-induced steatosis models.
Conclusions Bacteroides eggerthii ameliorates MASLD via gut-liver axis modulation, including bile acid metabolism and hepatic lipid signaling. These underscore its therapeutic potential and highlight HICA as a novel microbiome-derived metabolite with anti-steatotic activity.
Citations
Citations to this article as recorded by
Letter to the Editor: Circadian and microbial misalignment in metabolic dysfunction-associated steatotic liver disease - mechanistic insights and chronotherapeutic potential Christos Savvidis, Ioannis Ilias World Journal of Experimental Medicine.2026;[Epub] CrossRef
Decoding the Gut–Fat–Heart Axis: From Molecular Communication Networks to Clinical Translation Strategies Zijin Sun, Wei Shao, Haojia Zhang, Kai Wang, Yongchao Liu, Rui Zhou International Journal of Molecular Sciences.2026; 27(12): 5596. CrossRef
Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease, has become the most common form of chronic liver disease in children. The spectrum of pediatric MASLD ranges from simple steatosis to steatohepatitis, fibrosis, cirrhosis, and in rare cases, hepatocellular carcinoma. Its pathogenesis involves a complex interplay among genetic, epigenetic, and environmental factors, along with alterations in the gut microbiota and its associated metabolites. Given the staggering prevalence and the distinct etiopathogenesis of pediatric MASLD, characterization of the gut microbiota and microbial products could facilitate the development of diagnostic tools and inform targeted therapeutic strategies. Current research on the gut microbiome in the context of pediatric MASLD is limited by small sample size, inadequate use of liver biopsy, methodological inconsistencies in sequencing, and confounding effects from metabolic comorbidities. In this review, we summarize clinical studies on alterations in the gut microbiota and microbial products (short-chain fatty acids, bile acids, and ethanol) that impact the pathogenesis of pediatric MASLD. We discuss the therapeutic potential of dietary modification, pharmacological treatments, and probiotics in improving disease progression by summarizing current clinical studies. Enhancing our understanding of the gut-liver axis may aid in the development of effective therapeutic strategies for pediatric MASLD.
Citations
Citations to this article as recorded by
Obesity, Metabolic Syndrome and MASLD in Children: Inflammation as the Missing Link—A Short Narrative Review Mihaela-Andreea Podeanu, Claudiu Marinel Ionele, Raluca Elena Sandu, Ion Rogoveanu, Mioara Desdemona Stepan, Carmen Elena Niculescu, Sergiu-Marian Cazacu, Ștefănița Bianca Vintilescu Life.2026; 16(2): 310. CrossRef
Artificial intelligence for metabolic dysfunction-associated steatotic liver disease diagnosis: A systematic review Ruijuan Wang, Chang Liu, Mei Xue, Jun Qian, Yue Hu Computers in Biology and Medicine.2026; 208: 111619. CrossRef
Effects of metabolic syndrome on pulmonary infection in pediatric bronchial asthma: a narrative review Li He, Yang Ye Frontiers in Pediatrics.2026;[Epub] CrossRef
Microbial metabolites at the nexus of gut-brain communication and neurodevelopmental disorders Yupeng Lai, Ming Zhang, Dandan Lang, Enfu Tao Frontiers in Nutrition.2026;[Epub] CrossRef
Targeting the Human Gut Microbiota—Between Conventional Therapy and Precision Genetic Engineering Naomi-Adina Ciurea, Laura Mahdi, Annarita Graziani, Agostino Di Ciaula, Piero Portincasa, Mohamad Khalil Nutrients.2026; 18(12): 1958. CrossRef
Gut Microbiota–Metabolite Alterations Associated with Early Metabolic Dysfunction and Hepatic Steatosis in Adolescents Natalia Zeber-Lubecka, Paweł Czarnowski, Joanna Ziemska-Legięcka, Aldona Wierzbicka-Rucińska, Wojciech Jańczyk, Jacek Michałkiewicz, Łukasz Obrycki, Mieczysław Litwin, Michał Mikula, Piotr Socha, Jerzy Ostrowski Computational and Structural Biotechnology Journal.2026;[Epub] CrossRef
Background/Aims Evidence suggests that the gastrointestinal microbiome plays a significant role in the biology of metabolic dysfunction-associated steatotic liver disease (MASLD). However, it remains unclear whether disparities in the gut microbiome across intestinal tissular compartments between the sexes lead to MASLD pathogenesis.
Methods Sex-specific analyses of microbiome composition in two anatomically distinct regions of the gut, the small intestine and colon, were performed using an experimental model of MASLD. The study involved male and female spontaneously hypertensive rats and the Wistar-Kyoto control rat strain, which were fed either a standard chow diet or a high-fat diet for 12 weeks to induce MASLD (12 rats per group). High-throughput 16S sequencing was used for microbiome analysis.
Results There were significant differences in the overall microbiome composition of male and female rats with MASLD, including variations in topographical gut regions. The beta diversity of the jejunal and colon microbiomes was higher in female rats than in male rats (PERMANOVA p-value=0.001). Sex-specific analysis and discriminant features using LEfSe showed considerable variation in bacterial abundance, along with distinct functional properties, in the jejunum and colon of animals with MASLD. Significantly elevated levels of lipopolysaccharide and protein expression of Toll-like receptor 4 were observed in the livers of male rats with MASLD compared with their female counterparts.
Conclusions This study uncovered sexual dimorphism in the gut microbiome of MASLD and identified microbial heterogeneity within intestinal compartments. Insights into sex-specific variations in gut microbiome composition could facilitate customised treatment strategies.
Citations
Citations to this article as recorded by
Sex and gender differences in metabolic dysfunction-associated liver disease Rishitha Penmetsa, Sasha Kapil, Lisa B. VanWagner Indian Journal of Gastroenterology.2026; 45(2): 192. CrossRef
New Definition, New Point of View: Sex and Gender Interpretation of MASLD—Interpretation of Guidelines and Review of the Literature Massimo De Luca, Rita Verdoliva, Anna Lombardi, Antonio Giorgio Gastroenterology Insights.2026; 17(1): 7. CrossRef
The Gut–Liver Axis in MASLD: From Host–Microbiome Crosstalk to Precision Therapeutics Ji Zhou, Bowen Zhu, Ziqian Bing, Tingting Wang, Yue Zhao Microorganisms.2026; 14(2): 471. CrossRef
Sex-specific dynamics of MASLD reveal early hepatic and extrahepatic metabolic deterioration in females despite long-term protection Maria Repollés-de-Dalmau, Anna Marsal-Beltran, Catalina Núñez-Roa, Joan Vendrell, Victòria Ceperuelo-Mallafré, Sonia Fernández-Veledo Biology of Sex Differences.2026;[Epub] CrossRef
Sex-specific cardiometabolic phenotypes in MASLD: 3PM-centric stratification and trajectory mapping for proactive risk assessment Carlos José Pirola, Luis Diambra, Tomas Fernández Gianotti, Silvia Sookoian EPMA Journal.2026; 17(2): 387. CrossRef
Dysregulation of the Gut-Adipose Tissue-Liver Axis: a Possible Mechanism Behind the Relationship Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes Susanna Longo, Tommaso Giovanni Rinaldi, Jose Manuel Fernández-Real, Massimo Federici Current Diabetes Reports.2026;[Epub] CrossRef
Correspondence to letter to the editor on “Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunctionassociated steatotic liver disease” Eiji Kakazu, Masaaki Mino, Tatsuya Kanto Clinical and Molecular Hepatology.2026; 32(2): e235. CrossRef
Sex differences in the gut microbiome and related metabolites: role in cardiometabolic disease Yi Wang, En Cheng, Brandilyn A. Peters-Samuelson Gut Microbes.2026;[Epub] CrossRef
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women Ilaria Milani, Marianna Chinucci, Frida Leonetti, Danila Capoccia Biomedicines.2025; 13(4): 855. CrossRef
Characteristics of serum bile acid profiles among individuals with metabolic dysfunction-associated steatotic liver disease Sheng Lyu, Jiani Yang, Xin Xin, Qinmei Sun, Beiyu Cai, Xin Wang, Ziming An, Jian Sun, Yiyang Hu, Lei Shi, Qin Feng, Xiaojun Gou BMC Gastroenterology.2025;[Epub] CrossRef
Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease Chao Cui, Shuai Gao, Jingfei Shi, Kai Wang Gut and Liver.2025; 19(4): 479. CrossRef
Triglyceride-glucose-waist circumference index: A powerful tool for metabolic dysfunction-associated steatotic liver disease Bryan Adrian Priego-Parra, Berenice M Román-Calleja, Rocio Gallego-Duran, Jordi Gracia-Sancho, Jose Antonio Velarde Ruiz-Velasco, Jose Maria Remes-Troche World Journal of Hepatology.2025;[Epub] CrossRef
Animal models of lean metabolic dysfunction-associated steatotic liver disease (MASLD): bridging pathogenesis and novel drug discovery Stavros P. Papadakos, Chara Georgiadou, Eva Kassi, Rallia-Iliana Velliou, Antonios Chatzigeorgiou Expert Opinion on Drug Discovery.2025; 20(12): 1683. CrossRef
Na Young Lee, Min Jea Shin, Gi Soo Youn, Sang Jun Yoon, Ye Rin Choi, Hyeong Seop Kim, Haripriya Gupta, Sang Hak Han, Byoung Kook Kim, Do Yup Lee, Tae Sik Park, Hotaik Sung, Byung Yong Kim, Ki Tae Suk
Clin Mol Hepatol 2021;27(1):110-124. Published online December 3, 2020
Background/Aims Nonalcoholic fatty liver disease (NAFLD) is closely related to gut-microbiome. There is a paucity of research on which strains of gut microbiota affect the progression of NAFLD. This study explored the NAFLD-associated microbiome in humans and the role of Lactobacillus in the progression of NAFLD in mice.
Methods The gut microbiome was analyzed via next-generation sequencing in healthy people (n=37) and NAFLD patients with elevated liver enzymes (n=57). Six-week-old male C57BL/6J mice were separated into six groups (n=10 per group; normal, Western, and four Western diet + strains [109 colony-forming units/g for 8 weeks; L. acidophilus, L. fermentum, L. paracasei, and L. plantarum]). Liver/body weight ratio, liver pathology, serum analysis, and metagenomics in the mice were examined.
Results Compared to healthy subjects (1.6±4.3), NAFLD patients showed an elevated Firmicutes/Bacteroidetes ratio (25.0±29.0) and a reduced composition of Akkermansia and L. murinus (P<0.05). In the animal experiment, L. acidophilus group was associated with a significant reduction in liver/body weight ratio (5.5±0.4) compared to the Western group (6.2±0.6) (P<0.05). L. acidophilus (41.0±8.6), L. fermentum (44.3±12.6), and L. plantarum (39.0±7.6) groups showed decreased cholesterol levels compared to the Western group (85.7±8.6) (P<0.05). In comparison of steatosis, L. acidophilus (1.9±0.6), L. plantarum (2.4±0.7), and L. paracasei (2.0±0.9) groups showed significant improvement of steatosis compared to the Western group (2.6±0.5) (P<0.05).
Conclusions Ingestion of Lactobacillus, such as L. acidophilus, L. fermentum, and L. plantarum, ameliorates the progression of nonalcoholic steatosis by lowering cholesterol. The use of Lactobacillus can be considered as a useful strategy for the treatment of NAFLD.
Citations
Citations to this article as recorded by
Black Sesame Pigment Ameliorates Non-Alcoholic Fatty Liver Disease via Modulation of the Gut–Liver Axis and HIF-1 Signaling Pathway Qian Huang, Zhuowen Liang, Qingpeng Li, Ke Wang, Shuang Zhu, Wei Xiao, Lin Zhou Antioxidants.2026; 15(2): 177. CrossRef
Alteration in tongue coating microbiota across different stages of hepatitis B virus-related chronic liver disease Umar Pervaiz, Fuxia Wu, Pervaiz Nabeel, Rui Zhao, Zhengbin Zhao, Yibao Zhang, Peng Xia, Pengfei Ji, Xinyi Yuan, Xiaohui Hu, Zhao Guo, Kun Xie, Fang Wang, Degui Wang Journal of Oral Microbiology.2026;[Epub] CrossRef
Probiotics for managing non-alcoholic fatty liver disease: efficacy and mechanistic insights Supriyo Ghosh, Amlan Jyoti Ghosh, Manab Deb Adhikari, Bipransh Kumar Tiwary, Tilak Saha Journal of Diabetes & Metabolic Disorders.2026;[Epub] CrossRef
Advances in Cholesterol Regulation by
Lactobacillus
: Technical Approaches, Mechanisms of Action, and Potential for Clinical Translation
Jingjing Wang, Yuxin Wang, Yangying Sun, Xiaojiao Zheng, Xiaoqun Zeng, Zhen Wu, Daodong Pan, Maolin Tu Food Reviews International.2026; 42(5): 3760. CrossRef
Lactobacillus murinus Alleviates High Fructose‐Induced MASLD by Boosting Arginine Production Xinglin Mo, Guilin Zhao, Lanlan Liu, Lan Zhen, Qing Huang, Yue Wang, Xiaopan Yang, Linfei Huang, Luming Wan, Congwen Wei, Ruzhou Zhao, Jie Hu, Yong Li, Jing Yuan, Chenke Ma, Feixiang Wu Food Science & Nutrition.2026;[Epub] CrossRef
Lacticaseibacillus rhamnosus B6 alleviates metabolic dysfunction-associated fatty liver disease by suppressing intestinal LPS synthesis and regulating lipid metabolism Danqi Wang, Jin Han, Xiaohua Wang, Jing Wang, Chunping You, Zhengjun Wu Frontiers in Endocrinology.2026;[Epub] CrossRef
Long-term systemic effects of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD/MAFLD) in children: a systematic review of persistence and progression into adulthood Beatriz Rey-Garcia, Maria Teresa Reyes-Chacon, Eduardo Rosas-Blum, Marie Leiner Annals of Hepatology.2026; 31(1): 102197. CrossRef
Hepatoprotective effect of administering a probiotic strain (Lactobacillus acidophilus) to mice when consuming sucrose Marco Soria-Mamani, Oscar Gustavo Huaman Gutierrez Nutrire.2026;[Epub] CrossRef
Pathogenesis of fatty liver haemorrhagic syndrome in laying hens and advances in nutritional intervention through feed additives Lanlan Li, Jie Gao, Xin Wang, Yujiao Lai, Zhengfan Zhang, Shuangshuang Guo, Binying Ding World's Poultry Science Journal.2026; 82(3): 915. CrossRef
MASLD and MASLD-associated HCC: emerging biomarkers and therapeutic avenues Suki Ha, Xiang Zhang, Lanjuan Li, Jun Yu Science Bulletin.2026; 71(11): 2916. CrossRef
Diabetes and Obesity as Catalysts in MASH Progression: Mechanisms and Emerging Therapies Bhumika Munda, Chimila Bhutia, Deepti, Manisha Khatri Letters in Applied NanoBioScience.2026;[Epub] CrossRef
Obesity, type 2 diabetes, and the gut microbiome: A case-control investigation of L. acidophilus, L. rhamnosus, and B. bifidum Niloofar Sadooghi, Amir Mohammad Salimi Sharif, Soheil Rahmani Fard, Somayeh Soleymanzadeh Moghadam, Sara Minaeian Endocrine and Metabolic Science.2026; 21: 100308. CrossRef
Lactobacillaceae in Acute and Chronic Liver Diseases: From Microbiota Modulation to Therapeutic Potential Xulan Zhang, Yi Xia, Feng Ji Probiotics and Antimicrobial Proteins.2026;[Epub] CrossRef
Probiotic Bifidobacterium bifidum BGN4 supplementation modulates gut microbiome composition and reduces circulating zonulin, TNFα, and insulin in adults with excess adiposity: a randomized, double-blind, placebo-controlled trial Ju-Won Choi, Hyeyoon Kim, Sung-Hee Ham, Ye-Jin Han, Sung-Eun Kim, Mi-Kyung Sung Nutrition & Metabolism.2026;[Epub] CrossRef
Dietary milk polar lipids ameliorate hepatic lipid accumulation through coordinated regulation of Wnt-PPARγ signaling and remodeling of the gut microbiota Hajin Kim, Dongjun Park, Yea-ji Kwon, Jee-Young Imm Food Science of Animal Resources.2026;[Epub] CrossRef
Correspondence to editorial on “Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-hydroxytryptamine production” Dianji Tu, Cheng Lu, Bo Tang, Shiming Yang Clinical and Molecular Hepatology.2026; 32(3): e358. CrossRef
Роль биологически активных соединений в кисломолочных продуктах геродиетической направленности
Анна Васильевна Бегунова, Сергей Владимирович Симоненко, Елена Сергеевна Симоненко, Елена Сергеевна Семенова Food processing industry.2026; (8): 154. CrossRef
Serum–Cecal Metabolome Integration Predicts Gut Microbial Communities and Reveals Pathway-Level Host–Microbe Crosstalk Under Disease-Induced Dysbiosis Anil Kumar Baidya, Palok Aich OMICS: A Journal of Integrative Biology.2026;[Epub] CrossRef
Potential mechanisms by which microbiota-accessible carbohydrates regulate hepatic lipid metabolism in MAFLD via the gut-liver axis Jingyi Peng, Xiaojiao Gao, Guanglei Chen, Ankangxin Yan, Qi Yu, Weiyi Tian, Kun Cai Frontiers in Microbiology.2026;[Epub] CrossRef
Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin Pathway Jin-Ju Jeong, Yoo-Jeong Jin, Raja Ganesan, Hee Jin Park, Byeong Hyun Min, Min Kyo Jeong, Sang Jun Yoon, Mi Ran Choi, Satya Priya Sharma, You Jin Jang, Uigi Min, Jong-Hyun Lim, Kyeong Min Na, Jieun Choi, Sang Hak Han, Young Lim Ham, Do Yup Lee, Byung-Yong Probiotics and Antimicrobial Proteins.2025; 17(5): 2894. CrossRef
Comparative effects of viable Lactobacillus rhamnosus GG and its heat‐inactivated paraprobiotic in the prevention of high‐fat high‐fructose diet‐induced non‐alcoholic fatty liver disease in rats Laura Isabel Arellano‐García, Iñaki Milton‐Laskibar, J. Alfredo Martínez, Miguel Arán‐González, María P. Portillo BioFactors.2025;[Epub] CrossRef
Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction‐associated steatotic liver disease: a comprehensive review Jie‐Lun Ku, Jia‐Rou Hsu, Yung‐Tsung Li, Li‐Ling Wu Journal of Gastroenterology and Hepatology.2025; 40(1): 33. CrossRef
The Role of the Gut Microbiome in the Development and Progression of Type 2 Diabetes and Liver Disease Asha Guraka, Sreejesh Sreedharan, Ramesh Arasaradnam, Gyan Tripathi, Ali Kermanizadeh Nutrition Reviews.2025; 83(7): e2025. CrossRef
Research hotspots and trends in gut microbiota and nonalcoholic fatty liver disease: A bibliometric study Cai-Yun Huang, Zhong-Zhi Luo, Wei-Ping Huang, Li-Ping Lin, You-Ting Yao, Han-Xu Zhuang, Qiu-Yong Xu, Ya-Dong Lai World Journal of Hepatology.2025;[Epub] CrossRef
Gut microbiota: A new key of understanding for Panax notoginseng against multiple disorders and biotransformation Yueting Mo, Xiyuan He, Hao Cui, Yifan Cheng, Mingmei Zhou, Xiuming Cui, Ting Zhang Journal of Ethnopharmacology.2025; 341: 119306. CrossRef
Microbiota Co-Metabolism Alterations Precede Changes in the Host Metabolism in the Early Stages of Diet-Induced MASLD in Wistar Rats María Martín-Grau, Pilar Casanova, Laura Moreno-Morcillo, José Manuel Morales, Vannina G. Marrachelli, Daniel Monleón International Journal of Molecular Sciences.2025; 26(3): 1288. CrossRef
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo International Journal of Molecular Sciences.2025; 26(4): 1778. CrossRef
Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver disease Sang Yoon Lee, Su-Been Lee, Goo-Hyun Kwon, Seol Hee Song, Jeong Ha Park, Min Ju Kim, Jung A Eom, Kyeong Jin Lee, Sang Jun Yoon, Hyunjoon Park, Sung-Min Won, Jin-Ju Jeong, Ki-Kwang Oh, Young Lim Ham, Gwang Ho Baik, Dong Joon Kim, Satya Priya Sharma, Ki Tae Journal of Microbiology.2025; 63(2): e2411002. CrossRef
JiGuCao capsule formula alleviates metabolic fatty liver disease by regulating the gut–liver axis and lipid metabolism Wenying Qi, Xu Cao, Yue Chen, Hening Chen, Ningyi Zhang, Ruijia Liu, Wei Wang, Qiyao Liu, Shihao Zheng, Size Li, Xiaoke Li, Xiaobin Zao, Yong'an Ye Phytomedicine.2025; 140: 156559. CrossRef
Benefits of inulin and fructo-oligosaccharides on high fat diet-induced type 2 diabetes mellitus by regulating the gut microbiota in mice Xiaoqin Ding, Yan Chen, Lanlan Du, Jing Li, Xiuhua Meng, Han Lv, Bei Tong, Guanting Niu, Tunyu Jian, Jian Chen The Journal of Nutritional Biochemistry.2025; 141: 109908. CrossRef
Administration of a probiotic supplement attenuates nonalcoholic fatty liver disease by reducing hepatic lipid accumulation, oxidative stress, and inflammation Pennapa CHONPATHOMPIKUNLERT, Pratoomporn YINGTHONGCHAI, Suriya TATEING, Anuwat AMATACHAYA, Sasalux KAEWBUTRA, Neungnut CHAIYAWAN, Thanyarat LEKCHAOUM, Chaivarakun CHAIPANYA, Wachirawadee MALAKUL, Jurairat KHONGRUM Bioscience of Microbiota, Food and Health.2025; 44(2): 160. CrossRef
Integrating microbial GWAS and single-cell transcriptomics reveals associations between host cell populations and the gut microbiome Jingjing Li, Yunlong Ma, Yue Cao, Gongwei Zheng, Qing Ren, Cheng Chen, Qunyan Zhu, Yijun Zhou, Yu Lu, Yaru Zhang, Chunyu Deng, Wei-Hua Chen, Jianzhong Su Nature Microbiology.2025; 10(5): 1210. CrossRef
Harnessing
lactobacillus
: a probiotic revolution in combating metabolic dysfunction-associated steatotic liver disease
Minwen Gu, Qing Hong, Jie Cui, Wenhui Li, Jian Zhang, Ye Sun, Jinchi Jiang, Yonghong Hu Critical Reviews in Food Science and Nutrition.2025; 65(33): 8516. CrossRef
Effects of Lactobacillus fermentum GKF3 on Reducing Smoking and Brain Neurotransmitter Levels: Findings From Animal and Human Studies You‐Shan Tsai, Shan Lin, Chin‐Chu Chen, Chun‐Hung Chiu, Mei‐Chin Mong, Shu‐Ling Hu, Chi‐Hao Wu Food Frontiers.2025; 6(4): 2065. CrossRef
Exploring the mechanisms of tetrahydrocurcumin in ameliorating nonalcoholic steatohepatitis based on network pharmacology and gut microbiota analysis in vivo and in vitro Keyu Chen, Jianbo Wang, Shuang Luo, Yunyun Quan, Ping Wei, Jiali Fu, Jiali Ma, Yuying Yang, Yunten Liu, Zhichong Gao Frontiers in Microbiology.2025;[Epub] CrossRef
The liver-gut axis perspective: Exploring the pathogenesis of fatty liver Zonghui Yang, Jinbao Zhang, Xiaona Liu, Honggang Chen, Haijing Duan, Qian Wang, Wenlong Zhao, Ling Jin European Journal of Pharmacology.2025; 1002: 177822. CrossRef
Optimization of microwave-assisted extraction for quercetin (prebiotic) and the effect of its symbiotic combination with Lactobacillus acidophilus (probiotic) in NAFLD induced rat model Mehwish Majeed, Waqas Ahmed, Sumera Javad, Iahtisham-Ul-Haq, Summer Rashid, Rashida Perveen, Umar Farooq, Juweria Abid, Abdul Momin Rizwan Ahmad Frontiers in Nutrition.2025;[Epub] CrossRef
The Effects of Wuniuzao Green Tea on Mice With High‐Fat Diet‐Induced Liver Steatosis Yiwei Yuan, Jiangcheng Ye, Mingxiu Gong, Yifan Zhang, Qianqian Xu, Jin Zhao Food Science & Nutrition.2025;[Epub] CrossRef
Probiotics as a therapeutic strategy for metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis Jing Lu, Xiaoxiao Dong, Ziqi Gao, Huizhen Yan, Dilireba Shataer, Liang Wang, Yanan Qin, Minwei Zhang, Jiayi Wang, Jie Cui, Shengyang Zhou Current Research in Food Science.2025; 11: 101138. CrossRef
Gastrointestinal Microbial Involvement in Gallstone Formation: A Systematic Review Sirui Wan, Kun Xia, Yunpeng Liu, Hongzhi Xu Health and Metabolism.2025; : 3. CrossRef
Cistanche tubulosa glycosides ameliorate cognitive decline in APP/PS1 mice via modulation of gut microbiota and fatty acid metabolism: insights from multi-omics and experimental validation Rui Hou, Wei Song, Yi Nan, Yiyi Gong, Jieying Liu, Jialin Liu Frontiers in Pharmacology.2025;[Epub] CrossRef
MicrobiomeKG: bridging microbiome research and host health through knowledge graphs Skye L. Goetz, Amy K. Glen, Gwênlyn Glusman Frontiers in Systems Biology.2025;[Epub] CrossRef
Changes in viable cell counts and functional properties of lactic
acid bacteria products under simulated marine shipping
conditions Se-Won Lee, Joong Sang Cho, Jeong-Muk Lim, Do-Yoeon Jang, Jun Hur, Jun Jae Jung, Byung-Taek Oh Food Science and Preservation.2025; 32(4): 603. CrossRef
Stachyose Attenuates Hepatic Cholesterol Deposition in Nonalcoholic Fatty Liver Mice via Gut Microbiota-Driven Bile Acid Profile Remodeling Yanqi Li, Ying Fan, Yashi Zhang, Aizhen Zong, Fangling Du, Tongcheng Xu Journal of Agricultural and Food Chemistry.2025; 73(41): 26130. CrossRef
Akkermansia muciniphila: a microbial guardian against oxidative stress–gut microbiota crosstalk and clinical prospects Wen-Yu Ye, Yan Cai Journal of Translational Medicine.2025;[Epub] CrossRef
The Gut Health Revolution: Herbs and Dietary Phytochemicals in Balancing Gut Microbiota for Optimal Human Health Afeefa Khan, Sageer Abass, Syed Ali Imam Nizami, Mohd Shariq, Sultan Zahiruddin, Bushra Parveen, Rabea Parveen Current Pharmaceutical Biotechnology.2025; 26(14): 2339. CrossRef
Revealing the Causal Relationship of the Gut‐Liver Axis in MASH: A Study Based on Mendelian Randomization and Multi‐Omics Dapeng Yin, Jiacheng Cheng, Huili Cao, Xiaojuan Wang, Junhua He, Yikun Zhu, Jin Li The FASEB Journal.2025;[Epub] CrossRef
Lactobacillus gasseri TF08-1 ameliorates high-fat diet induced nonalcoholic fatty liver disease and regulates gut microbiota in mice Qianyue Xu, Ningning He, Yu Tian, Zhinan Wu, Haoyu Wang, Bei Liu, Zizhen Yang, Haifeng Zhang, Qiang Luo, Yiyi Zhong, Liang Xiao, Shangyong Li, Yuanqiang Zou Journal of Applied Microbiology.2025;[Epub] CrossRef
The Dual Role of Gut Microbiota and Their Metabolites in Hepatocellular Carcinoma: A Context-Dependent Framework Shuyu Zuo, Junhui Ma, Xue Li, Zhengyang Fan, Xiao Li, Yingen Luo, Lei Su Microorganisms.2025; 14(1): 73. CrossRef
Changes in viable cell counts and functional properties of lactic
acid bacteria products under simulated marine shipping
conditions Se-Won Lee, Joong Sang Cho, Jeong-Muk Lim, Do-Yoeon Jang, Jun Hur, Jun Jae Jung, Byung-Taek Oh Food Science and Preservation.2025; 32(4): 603. CrossRef
Pien Tze Huang Protects Against Non-Alcoholic Steatohepatitis by Modulating the Gut Microbiota and Metabolites in Mice Xianyi Zeng, Xiang Zhang, Hao Su, Hongyan Gou, Harry Cheuk-Hay Lau, Xiaoxu Hu, Ziheng Huang, Yan Li, Jun Yu Engineering.2024; 35: 257. CrossRef
The Effect of Heat-Killed Lactobacillus plantarum on Oxidative Stress and Liver Damage in Rats with Bile Duct Ligation-Induced Hepatic Fibrosis Shima Kabiri-Arani, Mitra Motallebi, Maryam Akhavan Taheri, Nejat Kheiripour, Abolfazl Ardjmand, Esmat Aghadavod, Mohammad Esmaeil Shahaboddin Probiotics and Antimicrobial Proteins.2024; 16(1): 196. CrossRef
Composition of gut microbiota and non‐alcoholic fatty liver disease: A systematic review and meta‐analysis Xin Su, Shiyun Chen, Jiazi Liu, Yonghui Feng, Eerdun Han, Xiaolei Hao, Minqi Liao, Jun Cai, Shiwen Zhang, Jianxiang Niu, Shihua He, Shaofen Huang, Kenneth Lo, Fangfang Zeng Obesity Reviews.2024;[Epub] CrossRef
Polysaccharide from Panax japonicus C.A. Mey prevents non-alcoholic fatty liver disease development based on regulating liver metabolism and gut microbiota in mice Yi Wu, Wen Yin, Ping Hao, Yueru Chen, Lingyun Yu, Xingjian Yu, Yu Wu, Xiaocong Li, Wenjia Wang, Hui Zhou, Yuan Yuan, Xiaoyu Quan, Yue Yu, Bing Hu, Shouhai Chen, Zhenlei Zhou, Wenjing Sun International Journal of Biological Macromolecules.2024; 260: 129430. CrossRef
Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction Wasitha P. D. W. Thilakarathna, H. P. Vasantha Rupasinghe Molecules.2024; 29(3): 709. CrossRef
Effects of selenium nanoparticles produced by Lactobacillus acidophilus HN23 on lipid deposition in WRL68 cells Xianglan Lei, Yuxuan Peng, Yan Li, Qianyuan Chen, Zhenguo Shen, Wen Yin, Viktar Lemiasheuski, Siyang Xu, Jin He Bioorganic Chemistry.2024; 145: 107165. CrossRef
Effects of dietary supplementation of fish oil plus vitamin D3 on gut microbiota and fecal metabolites, and their correlation with nonalcoholic fatty liver disease risk factors: a randomized controlled trial Xueqi Li, Chi Pan, Wenjun Ma, Ting Yang, Chong Wang, Weiwei Han, Wei Zhang, Hui Li, Zhongxia Li, Ting Zhao, Xiao-fei Guo, Duo Li Food & Function.2024; 15(5): 2616. CrossRef
New aspects characterizing non-obese NAFLD by the analysis of the intestinal flora and metabolites using a mouse model Wenji Zhang, Wenli Cheng, JingHui Li, Zhenrui Huang, Hui Lin, Wenjuan Zhang, Rosie Alegado mSystems.2024;[Epub] CrossRef
Differences among Lactiplantibacillus plantarum strains isolated from different fermented foods in their potential cholesterol-lowering properties Shu-Jun Guo, Chang-Cheng Li, Yu-Ting Feng, Yan-Ru Zhou, Bin Liu, Zhen-Peng Gao, Chun-Feng Guo Food Bioscience.2024; 59: 103847. CrossRef
Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001–2023) Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan Frontiers in Microbiology.2024;[Epub] CrossRef
Semaglutide alters gut microbiota and improves NAFLD in db/db mice Tuohua Mao, Chenxuan Zhang, Shuang Yang, Yingying Bi, Man Li, Jia Yu Biochemical and Biophysical Research Communications.2024; 710: 149882. CrossRef
Bacterial Community Influences the Effects of Lactobacillus acidophilus on Lipid Metabolism, Immune Response, and Antioxidant Capacity in Dogs Aipeng Mao, Xiaoli Chen, Weigang Zhao, Weixiao Nan, Yao Huang, Yalong Sun, Haihua Zhang, Chao Xu Animals.2024; 14(9): 1257. CrossRef
Impact of Synbiotic Intake on Liver Metabolism in Metabolically Healthy Participants and Its Potential Preventive Effect on Metabolic-Dysfunction-Associated Fatty Liver Disease (MAFLD): A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial Aakash Mantri, Anika Köhlmoos, Daniela Stephanie Schelski, Waldemar Seel, Birgit Stoffel-Wagner, Peter Krawitz, Peter Stehle, Jens Juul Holst, Bernd Weber, Leonie Koban, Hilke Plassmann, Marie-Christine Simon Nutrients.2024; 16(9): 1300. CrossRef
Therapeutic potential of Lactobacillus casei and Chlorella vulgaris in high-fat diet-induced non-alcoholic fatty liver disease (NAFLD)-associated kidney damages: a stereological study Haniyeh Keyghobadi, Hadis bozorgpoursavadjani, Farhad Koohpeyma, Nazanin Mohammadipoor, Marzieh Nemati, Farshad Dehghani, Iman Jamhiri, Gholamhossein Keighobadi, Sanaz Dastghaib Molecular Biology Reports.2024;[Epub] CrossRef
Small intestinal bacterial overgrowth in obese patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: a cross-sectional study Nicolás Ortiz-López, Ana María Madrid, Larissa Aleman, Alejandra Zazueta, Gladys Smok, Lucía Valenzuela-Pérez, Jaime Poniachik, Caroll J. Beltrán Frontiers in Medicine.2024;[Epub] CrossRef
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, Nikolaos Vythoulkas-Biotis, Andreas Adamou, Tatiana Zachariadou, Sofia Kargioti, Irene Karampela, Maria Dalamaga Metabolites.2024; 14(7): 366. CrossRef
Integrated serum metabolomics, 16S rRNA sequencing and bile acid profiling to reveal the potential mechanism of gentiopicroside against nonalcoholic steatohepatitis in lean mice Zeyun Li, Xueya Zhu, Chenhao Li, Ruiting Tang, Yuanyuan Zou, Shuaibing Liu Journal of Ethnopharmacology.2024; 334: 118526. CrossRef
Vinpocetine and Lactobacillus improve fatty liver in rats: role of adiponectin and gut microbiome Ahmed M. El-Baz, Ahmed Shata, Nehal A. Nouh, Lubna Jamil, Mohamed M. Hafez, Sally Negm, Attalla F. El-kott, Mohammed A. AlShehri, Eman M. Khalaf AMB Express.2024;[Epub] CrossRef
Physiological Effects of Lactic Acid Bacteria on Induced Non-Alcoholic Fatty Liver Disease in Male Laboratory Rats Mohammed F. Ayyed, Feryal F. Hussein, Mohammed J. Mohammed IOP Conference Series: Earth and Environmental Science.2024; 1371(6): 062019. CrossRef
Impact of Lactobacillaceae supplementation on the multi-organ axis during MASLD André A. Santos, Raquel Duarte, Madalena Duarte, Fabiola Arella, Vanda Marques, Stefan Roos, Cecília M.P. Rodrigues Life Sciences.2024; 354: 122948. CrossRef
Gut Microbiome and Metabolome Alterations in Overweight or Obese Adult Population after Weight-Loss Bifidobacterium breve BBr60 Intervention: A Randomized Controlled Trial Zhouya Bai, Ying Wu, Dejiao Gao, Yao Dong, Yujia Pan, Shaobin Gu International Journal of Molecular Sciences.2024; 25(20): 10871. CrossRef
The influence of perilipin 5 deficiency on gut microbiome profiles in murine metabolic dysfunction-associated fatty liver disease (MAFLD) and MAFLD-hepatocellular carcinoma Marinela Krizanac, Paula Štancl, Paola Berenice Mass-Sanchez, Rosa Karlić, Diana Moeckel, Twan Lammers, Anastasia Asimakopoulos, Ralf Weiskirchen Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef
Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease development Yangie Dwi Pinanga, Kyung-hee Pyo, Eun-Ae Shin, Haesong Lee, Eun Hae Lee, Wonsik Kim, Soyeon Kim, Ji Eon Kim, Semi Kim, Jung Weon Lee Life Sciences.2024; 358: 123164. CrossRef
Copper oxide nanoparticles induce non-alcoholic fatty liver disease by disrupting bile acid homeostasis and perturbing the intestinal microbial homeostasis Muran Jiang, Xiaoqi Tao, Yingxin Pang, Zongmin Qin, Erqun Song, Yang Song Journal of Hazardous Materials.2024; 480: 136416. CrossRef
Timing Matters: Late, but Not Early, Exercise Training Ameliorates MASLD in Part by Modulating the Gut‐Liver Axis in Mice Artemiy Kovynev, Zhixiong Ying, Sen Zhang, Emanuele Olgiati, Joost M. Lambooij, Clara Visentin, Bruno Guigas, Quinten R. Ducarmon, Patrick C. N. Rensen, Milena Schönke Journal of Pineal Research.2024;[Epub] CrossRef
The probiotic Lacticaseibacillus rhamnosus SD11 alleviates the progression of liver and colon damage through modulation of inflammation and tight junction proteins in streptozotocin-induced diabetic mice Waraporn Ruathong, Pissared Khuituan, Saranya Peerakietkhajorn, Rawee Teanpaisan, Jongdee Nopparat, Sayed Haidar Abbas Raza PLOS ONE.2024; 19(11): e0313395. CrossRef
Gut ecological networks reveal associations between bacteria, exercise, and clinical profile in non-alcoholic fatty liver disease patients Susanne Csader, Xiuqiang Chen, Howell Leung, Ville Männistö, Heikki Pentikäinen, Milla-Maria Tauriainen, Kai Savonen, Hani El-Nezami, Ursula Schwab, Gianni Panagiotou, Marc D. Cook mSystems.2023;[Epub] CrossRef
Tetrastigma hemsleyanumleaf extracts ameliorate NAFLD in mice with low-grade colitisviathe gut–liver axis Lihua Xiao, Hua Xiong, Zeyuan Deng, Xin Peng, Kejun Cheng, Hua Zhang, Li Jiang, Yong Sun Food & Function.2023; 14(1): 500. CrossRef
Protective Effects of Lactobacillus gasseri against High-Cholesterol Diet-Induced Fatty Liver and Regulation of Host Gene Expression Profiles Tianhua He, Nikita Lykov, Xu Luo, Huiling Wang, Zhanxiang Du, Ziyi Chen, Shitian Chen, Lin Zhu, Ye Zhao, Chimeng Tzeng International Journal of Molecular Sciences.2023; 24(3): 2053. CrossRef
Dendrobium officinale alleviates high-fat diet-induced nonalcoholic steatohepatitis by modulating gut microbiota Gege Tian, Wei Wang, Enrui Xia, Wenhui Chen, Shunzhen Zhang Frontiers in Cellular and Infection Microbiology.2023;[Epub] CrossRef
Effects of SCFAs and TMAO on non-alcoholic fatty liver disease indicating the therapeutic benefits of plant-based diet, and supplemental prebiotics, probiotics and synbiotics Vuong Vu, Young Mee Kim, Moonjae Cho Applied Biological Chemistry.2023;[Epub] CrossRef
Limosilactobacillus fermentum MG4294 and Lactiplantibacillus plantarum MG5289 Ameliorates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Mice Ji Yeon Lee, Minju An, Huijin Heo, Jeong-Yong Park, Junsoo Lee, Chang-Ho Kang Nutrients.2023; 15(8): 2005. CrossRef
Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) Margalida Monserrat-Mesquida, Cristina Bouzas, Catalina M. Mascaró, Silvia Tejada, Antoni Sureda Fermentation.2023; 9(4): 395. CrossRef
Ameliorating effect of probiotic on nonalcoholic fatty liver disease and lipolytic gene expression in rabbits Marina Aziz, Shabaan A. Hemeda, Ghadeer M. Albadrani, Sabreen E. Fadl, Fatma Elgendey Scientific Reports.2023;[Epub] CrossRef
Therapeutic mechanisms of the medicine and food homology formula Xiao-Ke-Yin on glucolipid metabolic dysfunction revealed by transcriptomics, metabolomics and microbiomics in mice Mei Li, Ding Cheng, Chuan Peng, Yujiao Huang, Jie Geng, Guangrui Huang, Ting Wang, Anlong Xu Chinese Medicine.2023;[Epub] CrossRef
Supplementation of Lactobacillus plantarum ATCC14917 mitigates non-alcoholic fatty liver disease in high-fat-diet-fed rats Xingjian Wen, Hejing Liu, Xiaoling Luo, Li Lui, Jiuyu Fan, Yajing Xing, Jia Wang, Xingfang Qiao, Na Li, Guixue Wang Frontiers in Microbiology.2023;[Epub] CrossRef
MicroRNA‐29a Compromises Hepatic Adiposis and Gut Dysbiosis in High Fat Diet‐Fed Mice via Downregulating Inflammation Ya‐Ling Yang, Ying‐Hsien Huang, Feng‐Sheng Wang, Ming‐Chao Tsai, Chien‐Hung Chen, Wei‐Shiung Lian Molecular Nutrition & Food Research.2023;[Epub] CrossRef
Brown adipose tissue-derived Nrg4 alleviates non-alcoholic fatty liver disease in mice Jing Luo, Ming Chen, Hongwu Ji, Weifeng Su, Wenkui Song, Di Zhang, Weiming Su, Shucheng Liu Journal of Functional Foods.2023; 108: 105735. CrossRef
Sanguisorba officinalis L. Ameliorates Hepatic Steatosis and Fibrosis by Modulating Oxidative Stress, Fatty Acid Oxidation, and Gut Microbiota in CDAHFD-Induced Mice Yunseong Nam, Myungsuk Kim, Saruul Erdenebileg, Kwang Hyun Cha, Da Hye Ryu, Ho Youn Kim, Su Hyeon Lee, Je Hyeong Jung, Chu Won Nho Nutrients.2023; 15(17): 3779. CrossRef
The PKA‐SREBP1c Pathway Plays a Key Role in the Protective Effects of Lactobacillus johnsonii JNU3402 Against Diet‐Induced Fatty Liver in Mice Eunjeong Hong, Hyuno Kang, Garam Yang, Sejong Oh, Eungseok Kim Molecular Nutrition & Food Research.2023;[Epub] CrossRef
Metagenomic signatures reveal the key role of phloretin in amelioration of gut dysbiosis attributed to metabolic dysfunction-associated fatty liver disease by time-dependent modulation of gut microbiome Jyoti Chhimwal, Prince Anand, Priyanka Mehta, Mohit Kumar Swarnkar, Vikram Patial, Rajesh Pandey, Yogendra Padwad Frontiers in Microbiology.2023;[Epub] CrossRef
Gut commensal Kineothrix alysoides mitigates liver dysfunction by restoring lipid metabolism and gut microbial balance Kyoung Jin Choi, Mi Young Yoon, Ji-Eun Kim, Sang Sun Yoon Scientific Reports.2023;[Epub] CrossRef
Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production Dong Yun Kim, Jun Yong Park, Heon Yung Gee Experimental & Molecular Medicine.2023; 55(11): 2332. CrossRef
Amlodipine, an anti‐hypertensive drug, alleviates non‐alcoholic fatty liver disease by modulating gut microbiota Yang Li, Danyang Zhao, Minyi Qian, Jun Liu, Chuyue Pan, Xinxin Zhang, Xubin Duan, Yufei Zhang, Wenxin Jia, Lirui Wang British Journal of Pharmacology.2022; 179(9): 2054. CrossRef
The Lactobacillus as a Probiotic: Focusing on Liver Diseases Jin-Ju Jeong, Hee Jin Park, Min Gi Cha, Eunju Park, Sung-Min Won, Raja Ganesan, Haripriya Gupta, Yoseph Asmelash Gebru, Satya Priya Sharma, Su Been Lee, Goo Hyun Kwon, Min Kyo Jeong, Byeong Hyun Min, Ji Ye Hyun, Jung A Eom, Sang Jun Yoon, Mi Ran Choi, Don Microorganisms.2022; 10(2): 288. CrossRef
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Yoseph Asmelash Gebru, Satya Priya Sharma, Eunju Park, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A. Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Do Biomedicines.2022; 10(3): 550. CrossRef
Modulatory effects of phenolics extract of Costus afer leaves on cadmium induced nephrotoxicity and hepatoxicity in Wistar rats Tope Gafar Atere, O. O. Oladokun, O. S. Osuntokun, K. I. Adedokun, J. O. Fatoki, S. A. Olawumi, O. S. Tokunbo, O. O. Obembe, O. S. Afolabi Toxicology and Environmental Health Sciences.2022; 14(2): 157. CrossRef
Usefulness of Probiotics in the Management of NAFLD: Evidence and Involved Mechanisms of Action from Preclinical and Human Models Laura Arellano-García, María P. Portillo, J. Alfredo Martínez, Iñaki Milton-Laskibar International Journal of Molecular Sciences.2022; 23(6): 3167. CrossRef
Docosahexaenoic acid-rich fish oil alleviates hepatic steatosis in association with regulation of gut microbiome in ob/ob mice Mohammed Said Moose Al-Bulish, Wanxiu Cao, Ruili Yang, Yuming Wang, Changhu Xue, Qingjuan Tang Food Research International.2022; 157: 111373. CrossRef
Walnut green husk ethanol extract improves gut microbiota and their metabolites associated with NLRP3 in non-alcoholic steatohepatitis Qionglian Fang, Xinping Li, Mengmeng Wang, Xue Qiao, Feng Huang, Chunyan Hu, Yongmei Xue, Shenglan Zhao, Yuping Lin Food & Function.2022; 13(11): 6387. CrossRef
Resilience and the Gut Microbiome: Insights from Chronically Socially Stressed Wild-Type Mice Malena dos Santos Guilherme, Francesco Valeri, Jennifer Winter, Marianne B. Müller, Andreas Schwiertz, Kristina Endres Microorganisms.2022; 10(6): 1077. CrossRef
The Potential Effect of Intestinal Flora and Metabolites on High-Fat Diet-Mediated Nonalcoholic Fatty Liver Disease 志伟 韩 Advances in Clinical Medicine.2022; 12(05): 4823. CrossRef
Gut microbiota mediates methamphetamine-induced hepatic inflammation via the impairment of bile acid homeostasis Kai-Kai Zhang, Jia-Li Liu, Li-Jian Chen, Jia-Hao Li, Jian-Zheng Yang, Ling-Ling Xu, Yu-Kui Chen, Qin-Yao Zhang, Xiu-Wen Li, Yi Liu, Dong Zhao, Xiao-Li Xie, Qi Wang Food and Chemical Toxicology.2022; 166: 113208. CrossRef
A Transcriptomic Response to Lactiplantibacillus plantarum-KCC48 against High-Fat Diet-Induced Fatty Liver Diseases in Mice Ilavenil Soundharrajan, Muthusamy Karnan, Jeong-Sung Jung, Kyung-Dong Lee, Jeong-Chae Lee, Thiyagarajan Ramesh, Dahye Kim, Ki-Choon Choi International Journal of Molecular Sciences.2022; 23(12): 6750. CrossRef
Gut Commensal Parabacteroides goldsteinii MTS01 Alters Gut Microbiota Composition and Reduces Cholesterol to Mitigate Helicobacter pylori-Induced Pathogenesis Chih-Ho Lai, Tzu-Lung Lin, Mei-Zi Huang, Shiao-Wen Li, Hui-Yu Wu, Ya-Fang Chiu, Chia-Yu Yang, Cheng-Hsun Chiu, Hsin-Chih Lai Frontiers in Immunology.2022;[Epub] CrossRef
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim Clinical and Molecular Hepatology.2022; 28(3): 425. CrossRef
Total Flavonoids from Chimonanthus nitens Oliv. Leaves Ameliorate HFD-Induced NAFLD by Regulating the Gut–Liver Axis in Mice Wenya Meng, Zitong Zhao, Lingli Chen, Suyun Lin, Yang Zhang, Jing He, Kehui Ouyang, Wenjun Wang Foods.2022; 11(14): 2169. CrossRef
Effects of garlic and its major bioactive components on non-alcoholic fatty liver disease: A systematic review and meta-analysis of animal studies Sara Shojaei-Zarghani, Mohammad Reza Fattahi, Asma Kazemi, Ali Reza Safarpour Journal of Functional Foods.2022; 96: 105206. CrossRef
Investigation of Gynura segetum root extract (GSrE) induced hepatotoxicity based on metabolomic signatures and microbial community profiling in rats Xinyi Gu, Shuwei Li, Mengna Lu, Ying Li, Qixue Wang, Long Chen, Yiqun Jia, Shan Cao, Ting Zhang, Mingmei Zhou, Xiaojun Gou Frontiers in Microbiology.2022;[Epub] CrossRef
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, Shan Liu, Tatsunori Miyata, Qiaoling Song, Qingda Wei, Chenyang Zhao, Chunhua Lin, Jinbo Yang Signal Transduction and Targeted Therapy.2022;[Epub] CrossRef
Depletion of Gut Microbiota Inhibits Hepatic Lipid Accumulation in High-Fat Diet-Fed Mice Hui Han, Mengyu Wang, Ruqing Zhong, Bao Yi, Martine Schroyen, Hongfu Zhang International Journal of Molecular Sciences.2022; 23(16): 9350. CrossRef
The Functional Roles of Lactobacillus acidophilus in Different Physiological and Pathological Processes Huijuan Gao, Xin Li, Xiatian Chen, Deng Hai, Chuang Wei, Lei Zhang, Peifeng Li Journal of Microbiology and Biotechnology.2022; 32(10): 1226. CrossRef
Adlay (Coix lacryma‐jobi L.) Polyphenol Improves Hepatic Glucose and Lipid Homeostasis through Regulating Intestinal Flora via AMPK Pathway Shengsuo Ma, Bing Yang, Yucong Shi, Yang Du, Yiwen Lv, Jiarong Liu, Enyan Liu, Huachong Xu, Li Deng, Xiao‐yin Chen Molecular Nutrition & Food Research.2022;[Epub] CrossRef
Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice Fang Xie, Hang-fei Xu, Jing Zhang, Xiao-ni Liu, Bu-xin Kou, Meng-yin Cai, Jing Wu, Jin-ling Dong, Qing-hua Meng, Yi Wang, Dexi Chen, Yang Zhang Frontiers in Immunology.2022;[Epub] CrossRef
Triglyceride: A mediator of the association between waist-to-height ratio and non-alcoholic fatty liver disease: A second analysis of a population-based study Haofei Hu, Yong Han, Yufei Liu, Mijie Guan, Qijun Wan Frontiers in Endocrinology.2022;[Epub] CrossRef
Genetic variants associated with circulating liver injury markers in Mexican Americans, a population at risk for non-alcoholic fatty liver disease Caroline M. Sabotta, Suet-Ying Kwan, Lauren E. Petty, Jennifer E. Below, Aron Joon, Peng Wei, Susan P. Fisher-Hoch, Joseph B. McCormick, Laura Beretta Frontiers in Genetics.2022;[Epub] CrossRef
Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives Yuqiu Han, Lanjuan Li, Baohong Wang Frontiers of Medicine.2022; 16(5): 667. CrossRef
Lactobacillus Species as Probiotics: Isolation Sources and Health Benefits Ameera M. Al-Yami, Abeer T. Al-Mousa, Sarah A. Al-Otaibi, Ashraf Y. Khalifa Journal of Pure and Applied Microbiology.2022; 16(4): 2270. CrossRef
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try Tian-Yi Ren, Xiao-Yan Li, Jian-Gao Fan Clinical and Molecular Hepatology.2021; 27(1): 83. CrossRef
Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Dose-Dependently Shifts the Gut Microbiome Consistent with the Progression of Non-Alcoholic Fatty Liver Disease Russell R. Fling, Timothy R. Zacharewski International Journal of Molecular Sciences.2021; 22(22): 12431. CrossRef
Mykotherapie bei Fettstoffwechselstörungen – wertvoller Beitrag von Vitalpilzen Dorothee Bös Erfahrungsheilkunde.2021; 70(05): 264. CrossRef
Isolation and Purification of β-Galactosidase Enzyme From Local Lactic Acid Bacteria Isolates to Overcome The Phenomenon of Non-Degradation of Milk Lactose Aisha A. Juma, Amin S. Badawy, Sanad B. Mohammed IOP Conference Series: Earth and Environmental Science.2021; 910(1): 012075. CrossRef
The probiotic effects of AB23A on high-fat-diet-induced non-alcoholic fatty liver disease in mice may be associated with suppressing the serum levels of lipopolysaccharides and branched-chain amino acids Fan Xia, Shijian Xiang, Zhijuan Chen, Luyao Song, Yuxin Li, Ziqiong Liao, Bingchen Ge, Benjie Zhou Archives of Biochemistry and Biophysics.2021; 714: 109080. CrossRef
First
Prev
